A phase I study of IRISOX (irinotecan/S-1/oxaliplatin) in the second-line treatment for gemcitabine-refractory pancreatic cancer

被引：0
|
作者：
Miyata, E. [1 ]
Okuwaki, K. [1 ]
Imaizumi, H. [2 ]
Kida, M. [1 ]
Iwai, T. [1 ]
Yamauchi, H. [1 ]
Kaneko, T. [1 ]
Hasegawa, R. [1 ]
Adachi, K. [1 ]
Tadehara, M. [1 ]
Koizumi, W. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Gastroenterol, Sagamihara, Kanagawa, Japan
[2] Sagamino Hosp, Japan Community Hlth Care Org, Gastroenterol, Sagamihara, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
721P
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
    T Ioka
    Y Komatsu
    N Mizuno
    A Tsuji
    S Ohkawa
    M Tanaka
    H Iguchi
    A Ishiguro
    M Kitano
    T Satoh
    T Yamaguchi
    K Takeda
    M Kida
    K Eguchi
    T Ito
    M Munakata
    T Itoi
    J Furuse
    C Hamada
    Y Sakata
    British Journal of Cancer, 2017, 116 : 464 - 471
  • [12] Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
    Ioka, T.
    Komatsu, Y.
    Mizuno, N.
    Tsuji, A.
    Ohkawa, S.
    Tanaka, M.
    Iguchi, H.
    Ishiguro, A.
    Kitano, M.
    Satoh, T.
    Yamaguchi, T.
    Takeda, K.
    Kida, M.
    Eguchi, K.
    Ito, T.
    Munakata, M.
    Itoi, T.
    Furuse, J.
    Hamada, C.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 464 - 471
  • [13] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Park, Se Jun
    Kim, Hyunho
    Shin, Kabsoo
    Lee, Myung Ah
    Hong, Tae Ho
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (11) : 1021 - 1030
  • [14] S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study
    Ge, Feijiao
    Xu, Nong
    Bai, Yuxian
    Ba, Yi
    Zhang, Yanqiao
    Li, Fei
    Xu, Huayan
    Jia, Ru
    Wang, Yan
    Lin, Li
    Xu, Jianming
    ONCOLOGIST, 2014, 19 (11): : 1133 - 1134
  • [15] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    S Ohkawa
    T Okusaka
    H Isayama
    A Fukutomi
    K Yamaguchi
    M Ikeda
    A Funakoshi
    M Nagase
    Y Hamamoto
    S Nakamori
    Y Tsuchiya
    H Baba
    H Ishii
    Y Omuro
    M Sho
    S Matsumoto
    N Yamada
    H Yanagimoto
    M Unno
    Y Ichikawa
    S Takahashi
    G Watanabe
    G Wakabayashi
    N Egawa
    M Tsuda
    R Hosotani
    C Hamada
    I Hyodo
    British Journal of Cancer, 2015, 112 : 1428 - 1434
  • [16] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    Ohkawa, S.
    Okusaka, T.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Hamamoto, Y.
    Nakamori, S.
    Tsuchiya, Y.
    Baba, H.
    Ishii, H.
    Omuro, Y.
    Sho, M.
    Matsumoto, S.
    Yamada, N.
    Yanagimoto, H.
    Unno, M.
    Ichikawa, Y.
    Takahashi, S.
    Watanabe, G.
    Wakabayashi, G.
    Egawa, N.
    Tsuda, M.
    Hosotani, R.
    Hamada, C.
    Hyodo, I.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1428 - 1434
  • [17] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Se Jun Park
    Hyunho Kim
    Kabsoo Shin
    Myung Ah Lee
    Tae Ho Hong
    World Journal of Gastrointestinal Oncology, 2019, (11) : 1021 - 1030
  • [18] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
    Morizane, C.
    Okusaka, T.
    Furuse, J.
    Ishii, H.
    Ueno, H.
    Ikeda, M.
    Najima, M.
    Hirokawa, S.
    Nakachi, K.
    Ogura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 206S - 206S
  • [19] Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
    Maeda, Shimpei
    Motoi, Fuyuhiko
    Onogawa, Tohru
    Morikawa, Takanori
    Shigeru, Ottomo
    Sakata, Naoaki
    Takadate, Tatsuyuki
    Naitoh, Takeshi
    Rikiyama, Toshiki
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 539 - 545
  • [20] Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
    Shimpei Maeda
    Fuyuhiko Motoi
    Tohru Onogawa
    Takanori Morikawa
    Ottomo Shigeru
    Naoaki Sakata
    Tatsuyuki Takadate
    Takeshi Naitoh
    Toshiki Rikiyama
    Yu Katayose
    Shinichi Egawa
    Michiaki Unno
    International Journal of Clinical Oncology, 2011, 16
12345